# Albert Max, Inc. – FDA Inspection, May 25, 2017

Source: https://www.keypedia.com/records/fda_inspections/albert-max-inc/0dffa158-6426-43a7-9712-e9cec50a3729
Source feed: FDA_Inspections

> FDA inspection 1014057 of Albert Max, Inc., May 25, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014057
- Company Name: Albert Max, Inc.
- Inspection Date: 2017-05-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1321612 - 2026-06-11](https://www.keypedia.com/records/fda_inspections/albert-max-inc/88e10afe-2c13-4dd4-b7eb-dd679718f55e)
- FDA Inspection 1142624 - 2021-04-15
- [FDA Inspection 989423 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/albert-max-inc/0d6d9a24-26c5-4814-9ad6-21bf94fc0182)
- [FDA Inspection 833396 - 2013-05-28](https://www.keypedia.com/records/fda_inspections/albert-max-inc/59cbe84e-fd7d-430d-a3e8-2cccf44628b6)
- FDA Inspection 584290 - 2009-05-19

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)

Company: https://www.keypedia.com/companies/albert-max-inc/250f0fb9-c382-4c19-9796-00bb80079b0a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c